78 cases of water Linjia treatment of non-alcoholic fatty liver disease observed.docVIP

 PAGE \* MERGEFORMAT 9 78 cases of water Linjia treatment of non-alcoholic fatty liver disease observed Of: Lili Wei, Feng Tian-jiao, Chen real [Abstract] Objective To observe the water Linjia (silybin - phospholipid complex) in the treatment of non-alcoholic fatty liver disease patients. Methods 56 patients were randomly divided into 2 groups to the water Linjia oral treatment group and control group I tiopronin oral, were 3 months for a course of treatment, after treatment, clinical symptoms, ALT, AST, TC, TG, and changes in ultrasound images. 2 patients were observed during the treatment of adverse reactions. the treatment group and the control group, the total effective rate was 89.3% and 71.4%, treatment group was significantly higher in group 2 there was significant difference (P lt;0.05). the treatment group in improving clinical symptoms, liver function, blood lipids and Ultrasonography terms of efficacy, no significant adverse reactions. Conclusion water Linjia treatment of non-alcoholic fatty liver disease have better clinical efficacy. [Keywords:] fatty liver; water Linjia; treatment outcome [Abstract] Objective To observe the clinical efficacy of silibinin capsules in patients with non alcoholic fatty liver disease (NAFLD). Methods 56 patients with NAFLD were randomly divided into a treatment group treated with silibinin capsules and a control group treated with tiopronin tablets respectively for consecutive 3 months. Before and 12 weeks after the treatment, the changes of clinical symptom, serum transaminase level (ALT / AST), cholestero (TC), triglyceride (TG) and ultrasonic image were dectected respectively.Adverse effect was also observed during the experiment.Results The total effective rate in the treatment group was 89.3%, which was higher than that in the control group (71.4%), showing significant difference statistically (Pgt; 0.05). Satisfactory effect was obtained in the improvement of clinical symptom, serum ALT / AST, TC, TG